IREN Faces a $6 Billion Question as Two Brokerages Split on the Same Stock
Published on 11/10/2026 at 20:31 | Editorial boerse-global.de
Two analyst notes landed on IREN this week with the same target in their sights but very different conclusions about what it is worth. CCB International cut its rating to "Neutral" from "Outperform" and set a $40 price target, while JPMorgan trimmed its own target to $55 from $65 but kept an "Overweight" rating. The divergence frames the real debate: can a company sitting on a $20.3 billion order backlog convert it into revenue fast enough to justify a build-out whose final $6 billion depends on market conditions?
The stock's reaction has been sharp. IREN fell 9.3% on the day of the CCB downgrade, according to one reading of the session, while a separate tally put the decline at 2.8%. Either way, the pressure follows a cluster of target cuts from other houses on Friday — Cantor Fitzgerald slashed its target to $47 from $99 while sticking with "Overweight," and four more brokerages lowered their targets into a range of $30 to $65 without changing their ratings. CCB was the only one of the group to move its recommendation.
The Numbers Behind the Split
IREN's fiscal first-quarter report, released Thursday, showed revenue of $228 million and a net loss of $263 million. Its AI cloud services business accounted for $200 million of the top line. The backlog of contracted revenue climbed 22% quarter over quarter to $20.3 billion — a figure that underpins the bull case but also raises the stakes on execution.
Should investors sell immediately? Or is it worth buying IREN?
Against that, IREN has laid out $15 billion in remaining planned capital spending for fiscal 2027. Of that, $9 billion is expected to come from cash on hand, committed GPU financing and prepayments. The other $6 billion hinges on market conditions — a phrase that gives investors little to work with and puts a premium on tangible financing progress.
The company has already taken one step on that front, closing a $363 million equipment financing agreement with Wingspire. The facility refinances existing AI computing hardware and frees up capital for investment. It is a modest piece of the puzzle next to the $6 billion gap, but it shows the financing machinery is moving.
A Deadline That Slipped
IREN now expects to hit an annualized recurring revenue run rate above $4 billion in January 2027, with a possible extension into February. The prior guidance had pointed to the end of 2026. Management blamed a customer-requested design change and scheduling with suppliers — the same factors behind delays in the broader build-out.
That pushed deadline is the next hard checkpoint for the growth story. If IREN holds the revised timeline and keeps making headway on financing, the backlog argument retains its force. If execution slips again while funding conditions tighten, the more cautious view — the one CCB adopted this week — gains credibility. Investors watching the name have two things to track in tandem: delivery against the revenue target and progress on the market-dependent slice of the capital plan. Only their combination will settle which of this week's two calls was right.
Ad
IREN Stock: New Analysis - 10 November
Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
